title: An outbreak of Serratia marcescens septicemia in neonates.
abstract: Serratia marcescens is a well recognized nosocomial pathogen. We report an outbreak with this organism in 8 neonates in a neonatal intensive care unit (NICU). Seven cases were treated successfully with meropenem after the failure of imipenem treatment. Although they have similar anti-microbial effects, meropenem can effectively treat the S. marcescens sepsis resistant to imipenem.
authors.affiliation: Department of Pediatric, Kahramanmaras Sutcu Imam University, Kahramanmaras 46050, Turkey. ekremguler@hotmail.com
authors.forename: Ekrem
authors.initials: E
authors.lastname: Guler
authors.forename: Mehmet
authors.initials: M
authors.lastname: Davutoglu
authors.forename: Hasan
authors.initials: H
authors.lastname: Ucmak
authors.forename: Hamza
authors.initials: H
authors.lastname: Karabiber
authors.forename: Omer Faruk
authors.initials: OF
authors.lastname: Kokoglu
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology*; D004196:Disease Outbreaks; D006801:Humans; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D000077731:Meropenem; D016868:Serratia Infections / Q000453:epidemiology*; D012706:Serratia marcescens; D013845:Thienamycins / Q000627:therapeutic use; D014421:Turkey / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents; D013845:Thienamycins; D000077731:Meropenem